OAC
JSPR icon

OMERS Administration Corp’s Jasper Therapeutics JSPR Stock Holding History

OMERS Administration Corp’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,260
Closed -$225K – 60
2021
Q1 		$225K Sell
2,260
-2,739
-55% -$279K ﹤0.01% 296
2020
Q4 		$500K Buy
+4,999
New +$497K 0.01% 180

Other funds holding JSPR

MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $879M AUM 29.99% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return

OMERS Administration Corp's JSPR Position: Q2 2021 in Review

OMERS Administration Corp sold out of Jasper Therapeutics (JSPR) in Q2 2021, closing a stake of 2,260 shares — an estimated $225K sold.

OMERS Administration Corp first reported a position in JSPR in Q4 2020 and held it in 2 quarters. The position peaked at $500K in Q4 2020. 57 funds tracked by Wall St. Rank hold JSPR as of Q2 2021.

  • OMERS Administration Corp reported no remaining Jasper Therapeutics position as of Q2 2021 after selling out during the quarter.
  • OMERS Administration Corp sold 2,260 Jasper Therapeutics shares in Q2 2021, an estimated $225K.
  • OMERS Administration Corp first reported a position in Jasper Therapeutics in Q4 2020 and held it in 2 quarters.
  • OMERS Administration Corp's Jasper Therapeutics position peaked at $500K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2021.

Based on OMERS Administration Corp's 13F filing for Q2 2021, filed 13 Aug 2021.